Skip to NavigationSkip to content

Pharmafile - Medical Communications

AstraZeneca's Imfinzi gets orphan drug designation from FDA
AstraZeneca’s cancer immunotherapy Imfinzi has been granted orphan drug status as a treatment for small cell lung cancer (SCLC).
Top Ten most popular articles on Pharmafile.com this week!
Top ten stories on Pharmafile.com
Bernie Sanders to join trip to Canada for cheaper insulin
Senator Bernie Sanders is set to join people with Type 1 diabetes on a trip to Canada in search of cheaper insulin.
Novartis and Amgen halt trials into Alzheimer's drug after patients get worse
Novartis, Amgen and Banner Alzheimer's Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient...
>> More Medical Communications News Stories

Features

Darius Hughes, Head of Vaccines Business Unit UK, Pfizer

“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” - Darius Hughes, Head of Vaccines Business...

>> More Features

Appointments

GSK hires computational drug design expert Dr Kim Branson as new head of machine learning and AI

British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President,...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches